| Literature DB >> 19768775 |
Abstract
Because over expression of Hsp70 molecular chaperones suppresses the toxicity of aberrantly folded proteins that occur in Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis, and various polyQ-diseases (Huntington's disease and ataxias), Hsp70 is garnering attention as a possible therapeutic agent for these various diseases. Here, I review progress in this fascinating field of molecular chaperones and neurodegeneration and describe our current understanding of the mechanisms by which Hsp70 protects cells from the PD-related protein called alpha-synuclein (alpha-syn). (c) 2009 Wiley Periodicals, Inc.Entities:
Mesh:
Substances:
Year: 2010 PMID: 19768775 DOI: 10.1002/bip.21302
Source DB: PubMed Journal: Biopolymers ISSN: 0006-3525 Impact factor: 2.505